Skip to content

Nuvectis Pharma

US · NVCT #3557 by market cap Listed 2022
19.85 -0.44 -2.17%
Live - 5344 symbols - heartbeat 366s ago · 2026-10-08 10:11
After-hours 20.29 0.00%
Market cap
647.98M
P/B
71.40
EPS
-1.32
Reader sentiment Are you bullish or bearish on NVCT?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $13
    Market Newswire · 2026/6/13
  • Roth MKM Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $33
    Market Newswire · 2026/7/6
  • Rating change
    Lucid Capital Initiates Nuvectis Pharma(NVCT.US) With Buy Rating, Announces Target Price $18
    Market Newswire · 2025/2/26
  • Rating change
    Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $22
    Market Newswire · 2026/6/23
  • Rating change
    Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/6/11
  • Rating change
    Maxim Group Initiates Nuvectis Pharma(NVCT.US) With Buy Rating, Announces Target Price $17
    Market Newswire · 2025/4/3
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT), Tenet Healthcare (THC) and Upstream Bio, Inc. (UPB)
    TipRanks · 2026/2/12
  • Rating change
    H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $39
    Market Newswire · 2026/6/22
  • Rating change
    Laidlaw Initiates Nuvectis Pharma(NVCT.US) With Buy Rating, Announces Target Price $19
    Market Newswire · 2025/3/18
  • Rating change
    H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $10
    Market Newswire · 2026/5/5
  • Rating change
    Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $30
    Market Newswire · 2026/6/24
  • Rating change
    Roth MKM Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $33
    Market Newswire · 2026/7/6
  • Rating change
    H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $15
    Market Newswire · 2025/7/10
  • H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $39
    Market Newswire · 2026/9/24
  • Rating change
    H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $15
    Market Newswire · 2025/5/1
  • Rating change
    H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Cuts Target Price to $10
    Market Newswire · 2025/8/4
  • Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $34
    Market Newswire · 2026/8/5
  • Rating change
    H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $13
    Market Newswire · 2026/6/15
  • Cantor Fitzgerald Initiates Nuvectis Pharma(NVCT.US) With Buy Rating
    Market Newswire · 2026/8/24
  • Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $30
    Market Newswire · 2026/9/26

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 10:11:01 · For reference only, not investment advice and not tailored to your situation.